Storm Therapeutics
Edit

Storm Therapeutics

http://www.stormtherapeutics.com/
Last activity: 18.05.2023
Categories: LEDInformationDrugDevelopmentBioTechAnalyticsUniversityPlatformNewsLegalTech
STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.
Followers
801
Website visits
5.6K /mo.
Mentions
31
Location: United Kingdom, England, Cambridge
Employees: 11-50
Total raised: $89.62M
Founded date: 2015

Investors 5

Funding Rounds 4

DateSeriesAmountInvestors
19.12.2022Series B$30M-
20.05.2019Series A$38.18MSeroba Lif...
09.01.2018Series A$5.41M-
28.06.2016-$16.03M-

Mentions in press and media 31

DateTitleDescriptionSource
19.12.2022STORM Therapeutics announces closing of USD $30M Series B fi...14 December, 2022. Cambridge, England. STORM Therapeutics Ltd. (STORM), the clinical biotechnology c...seroba-lif...
14.12.2022STORM Therapeutics Ltd - STORM Therapeutics announces closin... STORM Therapeutics announces closing of USD $30M Series B financing Proceeds will advance STO...ipgroupplc...
14.12.2022Storm Therapeutics Closes USD $30M Series B FinancingStorm Therapeutics, a Cambridge, UK-based clinical biotechnology company, raised $30M in Series B fi...finsmes.co...
14.12.2022STORM Therapeutics announces closing of USD $30M Series B fi...STORM Therapeutics announces closing of USD $30M Series B financing Proceeds will advance STORM’s p...cic.vc/new...
23.11.2022STORM Therapeutics doses first patient with oral METTL3 targ...STORM Therapeutics doses first patient with oral METTL3 targeting drug in a solid tumor Phase 1 stud...cic.vc/new...
23.11.2022STORM Therapeutics doses first patient with oral METTL3 targ...STC-15 is the first molecule specifically targeting an RNA methyltransferase to enter clinical devel...einpresswi...
20.10.2022STORM Therapeutics to present new data on its lead program S...STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposi...cic.vc/new...
12.09.2022Fierce Biotech names STORM Therapeutics as one of its “Fierc...Fierce Biotech names STORM Therapeutics as one of its “Fierce 15” Biotech Companies of 2022 STORM r...cic.vc/new...
04.05.2022STORM Therapeutics funded to fight coronavirus diseasesSTORM Therapeutics funded to fight coronavirus diseases Business Weekly article | By Tony Quested ...cic.vc/new...
14.10.2021Exelixis and STORM enter into exclusive collaboration to dis...Exelixis and STORM Therapeutics enter into exclusive collaboration and license agreement to discover...cic.vc/new...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In